Abbott

‘Sell More, Earn More’: Drug Company Reps Bribe Quack Doctors to Prescribe Anti-Biotics

New Exposé Paints Sorry Picture of India’s Medical Device Industry, Regulator Framework

Big Pharma Firms May Have ‘Underpaid’ Rs 530 Crore in Indian Taxes: New Report

A Scrapped Clinical Trial Shows How a Drug Might Work While the Trial Fails

Abbott Fails to Comply With India’s Directive on Safety but Withdraws Its Stents Anyway

Abbott's Absorb stent, which dissolves back into the bloodstream over time. Photo courtesy: Abbott

Amidst Safety Fears, India Sends Controversial Abbott Stent for Clinical Trials, Won’t Pull It Back

Government’s Cap on the Absurdly High Prices of Stents is a Good First Step